For those questioning what might happen here as we progress I...

For those questioning what might happen here as we progress I say look at the results for the 1b trials.......it's the only data you'll be able to make an informed decision on imo.......looking at estimated finishing dates and so on and trying to ascribe meaning (good or bad) will have us running in circles, we just can't know, and after all, they are only estimates...........

BTX 1503 1b data tells me there's a very good probability that this could well be 'game-changer' type product they're developing (along with the three others in the pipeline).........that's my one sentence evaluation fwiw.

"BTX 1503 is a safe and well tolerated topical treatment that addresses all of the 3 causes of acne".........unlike the competitors.........and with Permetrex we are able to deliver lower effective dose levels significantly enhancing the possibility that it can be used safely for an extensive time period............




The results BOT presented for 1b 1503 spoke for themselves I think, there is no reason to think they will produce wildly different outcomes in phase 2 trials imo..........but of course anything is possible...........think on the results and consider if they do anything other than show a successful outcome thus far...........to me they suggest that any significantly different outcomes that might be seen in phase two should be positive in nature.

I'll throw this into the mix as well.............(everyone here would've seen this by now but one more look bolsters the confidence)......this girl is beaming........hope we're in the same boat when they finally hand down the data. I'm a very confident holder here.............(and yes she could've been on the 'placebo' but we'll know soon enough).